- Home
- BP vs ZTS Comparison
BP vs ZTS Comparison
Compare BP & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BP
- ZTS
- Stock Information
- Founded
- BP 1889
- ZTS 1952
- Country
- BP United Kingdom
- ZTS United States
- Employees
- BP N/A
- ZTS N/A
- Industry
- BP Integrated oil Companies
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- BP Energy
- ZTS Health Care
- Exchange
- BP Nasdaq
- ZTS Nasdaq
- Market Cap
- BP 75.1B
- ZTS 73.2B
- IPO Year
- BP N/A
- ZTS 2013
- Fundamental
- Price
- BP $32.73
- ZTS $155.02
- Analyst Decision
- BP Hold
- ZTS Buy
- Analyst Count
- BP 11
- ZTS 8
- Target Price
- BP $33.11
- ZTS $211.50
- AVG Volume (30 Days)
- BP 12.5M
- ZTS 2.9M
- Earning Date
- BP 08-05-2025
- ZTS 08-05-2025
- Dividend Yield
- BP 5.82%
- ZTS 1.29%
- EPS Growth
- BP N/A
- ZTS 7.32
- EPS
- BP N/A
- ZTS 5.57
- Revenue
- BP $185,408,000,000.00
- ZTS $9,286,000,000.00
- Revenue This Year
- BP N/A
- ZTS $3.54
- Revenue Next Year
- BP $1.53
- ZTS $6.11
- P/E Ratio
- BP N/A
- ZTS $27.82
- Revenue Growth
- BP N/A
- ZTS 6.32
- 52 Week Low
- BP $25.23
- ZTS $139.70
- 52 Week High
- BP $35.83
- ZTS $200.33
- Technical
- Relative Strength Index (RSI)
- BP 66.25
- ZTS 39.36
- Support Level
- BP $31.01
- ZTS $156.26
- Resistance Level
- BP $31.69
- ZTS $161.77
- Average True Range (ATR)
- BP 0.83
- ZTS 3.29
- MACD
- BP 0.14
- ZTS -0.13
- Stochastic Oscillator
- BP 93.01
- ZTS 25.11
About BP BP p.l.c.
BP is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, it produced 1.2 million barrels of liquids and 6.9 billion cubic feet of natural gas per day. At the end of 2023, reserves stood at 6.8 billion barrels of oil equivalent, 55% of which are liquids. The company operates refineries with a capacity of 1.6 million barrels of oil per day.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.